| Smartgroup Corporation Ltd (SIQ) ORDINARY FULLY PAID |
Industrials |
$1,036 |
Becoming a substantial holder
|
19 Jul 2024 10:08AM |
$8.670 |
$7.680 |
fallen by
11.42%
|
|
| Omega Oil & Gas Limited (OMA) ORDINARY FULLY PAID |
Energy |
$77 |
Omega awards Canyon-1H contract to Halliburton
|
19 Jul 2024 10:07AM |
$0.213 |
$0.225 |
risen by
5.88%
|
|
OMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Halliburton awarded integrated drilling and completion services contract for Canyon-1H well.
- Site preparations and water bore drilling completed.
- Ensign rig #965 expected to arrive in late August 2024.
- Omega looks forward to leveraging Halliburton's expertise to maximize Canyon-1H's potential.
- Canyon-1H well to test Queensland’s Taroom Trough tight gas play.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$61 |
Response to ASX Query Letter
|
19 Jul 2024 9:59AM |
$0.038 |
$0.034 |
fallen by
10.53%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- LKE responded to ASX's query about compliance with Listing Rules 3.1 and 15.7.
- LKE confirmed that reduction in global headcount had been previously disclosed.
- LKE stated that the sale of non-core assets in Argentina was also previously announced.
- LKE asserted that no new material information was provided to the media.
- All disclosed information was part of ongoing internal processes and public announcements.
- LKE emphasized its adherence to its Continuous Disclosure Policy and Code of Conduct.
- LKE confirmed ongoing compliance with Listing Rule 3.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,651 |
Neuren receives Rare Pediatric Disease Designation from FDA
|
19 Jul 2024 9:59AM |
$20.780 |
$13.190 |
fallen by
36.53%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Neuren Pharmaceuticals Limited received Rare Pediatric Disease Designation from the FDA.
- The designation was granted for NNZ-2591 specifically for treating Phelan-McDermid syndrome.
- This designation qualifies Neuren for a potential priority review voucher (PRV).
- PRV can be used for priority review of a different product or sold to another sponsor.
- Neuren plans an End of Phase 2 Meeting with the FDA in Q3 2024 to discuss NNZ-2591.
- Phase 2 trial results demonstrated significant improvement in patients based on multiple efficacy measures.
- Neuren has orphan drug designations for all its programs in the United States.
- DAYBUE (trofinetide) is approved by the FDA for treating Rett syndrome.
- Neuren has a licensing agreement with Acadia Pharmaceuticals for trofinetide.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GBM Resources Limited (GBZ) ORDINARY FULLY PAID |
Materials |
$11 |
Noosa Mining Conference Presentation
|
19 Jul 2024 9:59AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$6 |
65% Increase in Palma Resource to 7.6Mt @ 2.0% CuEq
|
19 Jul 2024 9:58AM |
$0.125 |
$0.051 |
fallen by
59.20%
|
|
ALV - Price-sensitive ASX Announcement
Full Release
Key Points
- Alvo Minerals Limited announced a 65% increase in the high-grade mineral resource estimate (MRE) for the Palma Project.
- The updated MRE incorporates over 20km of new drilling data since the 2021 estimate.
- The total MRE now comprises 7.6 million tonnes at 2.0% copper equivalent (CuEq) or 6.2% zinc equivalent (ZnEq).
- Indicated Resources at deposits C1 and C3 total 3.3 million tonnes at 2.3% CuEq.
- A maiden Inferred MRE for the newly discovered C4 deposit is included, with 1.5 million tonnes at 1.8% CuEq.
- An open-pit mining scenario has been assumed for all deposits, constrained by conceptual open pits.
- Potential remains for further expansion and upgrading of resources through additional drilling at all deposits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$641 |
FY24 Trading Update & Guidance
|
19 Jul 2024 9:57AM |
$5.460 |
$8.350 |
risen by
52.93%
|
|
UNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong trading performance exiting FY24, with momentum continuing into July 2024
- Group sales expected to be $288.5 million, up 9.7% from FY23
- Universal Store LFL sales growth -0.3% in FY24 (H2 +6.6%)
- Perfect Stranger LFL sales growth +7.3% in FY24 (H2 +11.5%)
- Cheap Thrills Cycle (CTC) retail and online LFL sales growth +4.6% in FY24 (H2 +5.6%)
- CTC wholesale sales growth of +5.4% in FY24
- Underlying EBIT expected to be $46.0 million to $47.0 million (FY23: $40.4 million)
- FY24 period end net cash of approximately $14.3 million
- Total of 102 physical store locations as at 30 June 2024
- Positive sales trends continuing into the initial period of FY25 with over 15% total sales growth
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BNK Banking Corporation Limited (BBC) ORDINARY FULLY PAID |
Financials |
$37 |
Change of Company Secretary
|
19 Jul 2024 9:57AM |
$0.320 |
$0.315 |
fallen by
1.56%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$38 |
Resignation of Joint Company Secretary
|
19 Jul 2024 9:57AM |
$0.066 |
$0.180 |
risen by
172.73%
|
|
| Western Mines Group Ltd (WMG) ORDINARY FULLY PAID |
Materials |
$19 |
Notice of Extraordinary General Meeting & Proxy Form
|
19 Jul 2024 9:55AM |
$0.250 |
$0.215 |
fallen by
14%
|
|
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
$105 |
Response to ASX Price Query
|
19 Jul 2024 9:55AM |
$0.078 |
$0.110 |
risen by
41.03%
|
|
WA8 - Price-sensitive ASX Announcement
Full Release
Key Points
- WA8 confirms that it is in compliance with Listing Rules, specifically Listing Rule 3.1.
- WA8 is not relying on Listing Rule 3.1A for not making an announcement under Listing Rule 3.1.
- No information has ceased to be confidential which WA8 relied upon under Listing Rule 3.1A.
- WA8 is aware of information that could explain the recent trading in its securities and has made an announcement.
- Response to the ASX price query has been authorized and approved by the WA8 board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
$105 |
DD Program Expanded and High-Grade M1 Intercept Returned
|
19 Jul 2024 9:54AM |
$0.078 |
$0.110 |
risen by
41.03%
|
|
WA8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling activities along the 'Golden Corridor' are progressing well, with the current Reverse Circulation (RC) program complete and the diamond tails program expanded.
- The first diamond drilling at the Ricciardo and nearby M1 deposits in ten years has occurred.
- Significant high-grade assay results were obtained from the first diamond hole at the M1 deposit.
- The M1 deposit shows high-grade extension potential, which will be a focus in further drilling.
- Ricciardo and M1 are located within the 25km-long 'Golden Corridor' which hosts six discrete deposits with growth potential.
- Diamond drilling is expected to be completed by mid-August, with all assays expected by mid-September.
- An update of the Ricciardo Mineral Resource Estimate (MRE) is targeted for Q4 2024.
- Further drilling is planned for H2 2024 to focus on growth along the 'Golden Corridor'.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AustChina Holdings Limited (AUH) ORDINARY FULLY PAID |
Energy |
$3 |
Drilling Program Completed at Chenene Lithium Project
|
19 Jul 2024 9:53AM |
$0.003 |
$0.001 |
fallen by
66.67%
|
|
AUH - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling program completed at Chenene Lithium Project in Tanzania.
- Nine diamond core holes totaling 403.8 meters were drilled.
- Initial batch of 137 core samples sent for laboratory analysis with results expected in August.
- AustChina has a Binding Heads of Agreement with Cassius Mining for an Option to acquire the Chenene Project licenses.
- Project area covers 300km² in central Tanzania.
- Currently, the drill rig is being demobilized, and site rehabilitation is underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$8 |
Riversgold Investor Webinar
|
19 Jul 2024 9:51AM |
$0.007 |
$0.005 |
fallen by
30.77%
|
|
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$8 |
Riversgold Investor Presentation
|
19 Jul 2024 9:51AM |
$0.007 |
$0.005 |
fallen by
30.77%
|
|
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$493 |
Philip Lowe Appendix 3Y
|
19 Jul 2024 9:49AM |
$1.245 |
$1.205 |
fallen by
3.21%
|
|
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$397 |
Update - Proposed issue of securities - AMA
|
19 Jul 2024 9:48AM |
$0.052 |
$0.083 |
risen by
59.62%
|
|
| NeuroScientific Biopharmaceuticals Ltd (NSB) ORDINARY FULLY PAID |
Health Care |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
19 Jul 2024 9:43AM |
$0.040 |
$0.048 |
risen by
20%
|
|
NSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of pre-IND Meeting with the US FDA on EmtinB for advanced glaucoma
- Appointment of Dr. Tony Keating as an Executive Director on a part-time basis
- NeuroScientific's cash balance was A$4.954 million as of 30 June 2024
- Research and development activity payments during the quarter were A$93k
- Staff costs for the quarter were A$99k and administration costs were A$94k
- Payments to related parties during the quarter totaled A$77k
- Net cash burn level for the next quarter expected to be similar to the current quarter
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Smiles Group Limited (PSQ) ORDINARY FULLY PAID |
Health Care |
$288 |
Dividend/Distribution - PSQ
|
19 Jul 2024 9:42AM |
$1.800 |
$1.780 |
fallen by
1.11%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,749 |
Appendix 3C
|
19 Jul 2024 9:39AM |
$42.990 |
$51.200 |
risen by
19.10%
|
|
| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$8 |
Power completes technical due diligence at Lltio
|
19 Jul 2024 9:37AM |
$0.115 |
$0.060 |
fallen by
47.83%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- Power Minerals Limited completed technical due diligence at Lltio Niobium Project, Brazil.
- Legal due diligence is expected to be complete within two weeks.
- Initial sampling confirmed presence of niobium, tantalum, and rare earth elements.
- Power aims to prioritize targets for follow-up exploration through a systematic sampling program.
- The acquisition is strategically advantageous as it consolidates Power's position in South America.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,749 |
Appendix 3C
|
19 Jul 2024 9:37AM |
$42.990 |
$51.200 |
risen by
19.10%
|
|
| Petratherm Ltd (PTR) ORDINARY FULLY PAID |
Materials |
$99 |
Mabel Creek Gravity Survey - Revised
|
19 Jul 2024 9:37AM |
$0.022 |
$0.285 |
risen by
1,195.45%
|
|
| Cygnus Metals Limited (CY5) ORDINARY FULLY PAID |
Materials |
$61 |
Cleansing Notice
|
19 Jul 2024 9:37AM |
$0.060 |
$0.072 |
risen by
20%
|
|
| Pacific Smiles Group Limited (PSQ) ORDINARY FULLY PAID |
Health Care |
$288 |
Decision regarding Permitted Dividend
|
19 Jul 2024 9:35AM |
$1.800 |
$1.780 |
fallen by
1.11%
|
|
PSQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacific Smiles Group Limited resolved to pay a fully franked Permitted Dividend of $0.07 per share.
- Payment of the Permitted Dividend is subject to the Scheme becoming effective.
- The Permitted Dividend is based on Pacific Smiles' profits and equity reserves.
- The Implementation Date for the Permitted Dividend is expected to be 19 August 2024.
- If the Scheme becomes effective, shareholders will receive a total cash value of $1.90 per share.
- The total cash value includes $1.83 from Scheme Consideration and $0.07 from the Permitted Dividend.
- The declaration and payment of the Permitted Dividend will not reduce the aggregate consideration payable under the Scheme.
- Key dates include the Scheme Meeting on 1 August 2024 and the Second Court Hearing on 2 August 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
